dexagel 0,985 mg/g acu gels
bausch + lomb ireland limited, ireland - deksametazona nātrija fosfāts - acu gels - 0,985 mg/g
eplerenone accord 25 mg apvalkotās tabletes
accord healthcare b.v., netherlands - eplerenons - apvalkotā tablete - 25 mg
plecard 50 mg apvalkotās tabletes
sandoz d.d., slovenia - eplerenons - apvalkotā tablete - 50 mg
dexamethason krka 20 mg tabletes
krka, d.d., novo mesto, slovenia - deksametazons - tablete - 20 mg
dexamethason krka 4 mg tabletes
krka, d.d., novo mesto, slovenia - deksametazons - tablete - 4 mg
dexamethason krka 8 mg tabletes
krka, d.d., novo mesto, slovenia - deksametazons - tablete - 8 mg
plecard 25 mg apvalkotās tabletes
sandoz d.d., slovenia - eplerenons - apvalkotā tablete - 25 mg
carmustine medac (previously carmustine obvius)
medac gesellschaft für klinische spezialpräparate mbh - karmustīns - hodgkin disease; lymphoma, non-hodgkin - antineoplastiski līdzekļi - carmustine is indicated n adults in the following malignant neoplasms as a single agent or in combination with other antineoplastic agents and/or other therapeutic measures (radiotherapy, surgery): , brain tumours (glioblastoma, brain-stem gliomas, medulloblastoma, astrocytoma and ependymoma), brain metastases, secondary therapy in non-hodgkin’s lymphoma and hodgkin’s disease, as conditioning treatment prior to autologous haematopoietic progenitor cell transplantation (hpct) in malignant haematological diseases (hodgkin’s disease / non-hodgkin’s lymphoma).
enplerasa 25 mg apvalkotās tabletes
krka, d.d., novo mesto, slovenia - eplerenons - apvalkotā tablete - 25 mg
enplerasa 50 mg apvalkotās tabletes
krka, d.d., novo mesto, slovenia - eplerenons - apvalkotā tablete - 50 mg